ARGX:NASDAQ
argenx SE - ADR
$1,033.15
arrow_downward
-1.93%(-20.31) 1D
$1,033.15
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 4, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
$1,040.31
High
$1,048.44
Low
$1,031.19
Mkt. cap
64.86B
Avg. vol.
289.94K
Volume
125.06K
P/E ratio
39.25
52-wk high
$1,072.75
52-wk low
$661.85
EPS
$26.32
Beta
0.47
Shares outstanding
62.56M
No. of employees
2K
Open
$1,040.31
High
$1,048.44
Low
$1,031.19
Mkt. cap
64.86B
Avg. vol.
289.94K
Volume
125.06K
P/E ratio
39.25
52-wk high
$1,072.75
52-wk low
$661.85
EPS
$26.32
Beta
0.47
Shares outstanding
62.56M
No. of employees
2K
News stories
From web sources and news partners
AD HOC NEWS
·
11 hours ago
Argenx stock holds firm as biotech investors weigh recent clinical progress
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE - ADR